BeOne Medicines
ONC
#542
Rank
A$67.38 B
Marketcap
A$589.97
Share price
5.09%
Change (1 day)
16.46%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2023 (TTM): A-$25.10

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is A$8.67. In 2022 the company made an earnings per share (EPS) of A-$28.08 a decrease over its 2021 EPS that were of A-$22.05.

EPS history for BeOne Medicines from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A-$25.10-10.62%
2022A-$28.0827.35%
2021A-$22.05-19.96%
2020A-$27.5520.81%
2019A-$22.8031.52%
2018A-$17.34417.57%
2017A-$3.35-37.16%
2016A-$5.33158.95%
2015A-$2.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
A-$0.13-101.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
A-$1.38-115.89%๐Ÿ‡บ๐Ÿ‡ธ USA